Q4 2020 Holdings
Filed 2021-02-12 | 25 holdings | $90.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Altimmune Inc(ALT) | COM | 02155H200 | $50.8M | 4,500,000 | 56.2% |
| Celldex Therapeutics Inc(CLDX) | COM | 15117B202 | $14.0M | 800,000 | 15.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $12.6M | 1,954,932 | 14.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $12.2M | 1,088,817 | 13.5% |
| Constellation Pharmaceutical(CNST) | COM | 210373106 | $115.7K | 4,016,873 | 0.1% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $73.9K | 1,536,193 | 0.1% |
| Trillium Therapeutics Inc | COM | 89620X506 | $59.4K | 4,040,000 | 0.1% |
| Kinnate Biopharma Inc | COM | 49705R105 | $58.6K | 1,473,014 | 0.1% |
| Athira Pharma Inc | COM | 04746L104 | $57.9K | 1,691,623 | 0.1% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $47.4K | 672,306 | 0.1% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM | 56854Q200 | $31.6K | 2,588,941 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $24.8K | 1,115,255 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $21.4K | 668,440 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $18.8K | 575,000 | 0.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM | 92840H202 | $18.2K | 9,360,000 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $13.3K | 1,442,895 | 0.0% |
| Aligos Therapeutics Inc | COM | 01626L105 | $11.2K | 404,906 | 0.0% |
| Galera Therapeutics Inc(GRTX) | COM | 36338D108 | $9.4K | 917,860 | 0.0% |
| Silverback Therapeutics Inc(SPRY) | COM | 82835W108 | $7.0K | 150,000 | 0.0% |
| Bctg Acquisition Corp | COM | 05492W103 | $5.7K | 500,000 | 0.0% |
| Metacrine Inc | COM | 59101E103 | $5.5K | 693,673 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $4.2K | 245,122 | 0.0% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $3.4K | 100,000 | 0.0% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $2.9K | 107,982 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $321 | 19,495 | 0.0% |